- News
- Soleno Therapeutics
Tag:
Soleno Therapeutics
-
Neurocrine Biosciences has agreed to acquire Soleno Therapeutics for $2.9 billion in cash, the companies announced, marking a major expansion into treatments for metabolic disorders.06 Apr 2026-15:30
-